Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRADE: Gabapentin vs placebo in acute lumbosacral radiculalgia
2024-518053-42-00Phase 4Completed
- Sponsor
- Groupement des Hôpitaux de l'Institut Catholique de Lille
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in lumbosacral radiculopathy comparing Gabapentin with Placebo (2 arms). Primary endpoint: Change in radiculalgia pain VAS from Day 1 to Day 4. Started Oct 2024; status: completed.
02
Drugs
Gabament
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on 2024-518053-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518053-42-00.